A mutated flu strain, A H3N2, is spreading across Thailand with reduced vaccine effectiveness, warns Professor Yong ...

World-leading challenge study expertise helping deliver scalable, high-quality outpatient vaccine trials in healthy ...

An overview of how specialty laboratories use integrated scientific approaches to deliver high-quality infectious disease ...

Well-known virologist Yong Poovorawan has warned that a mutating influenza strain A H3N2 is spreading in Thailand. It is more resistant to vaccines but does not increase in severity.

First-in-human study evaluates safety, pharmacokinetics, biomarker analyses, target engagement, and anti-tumor activity in ...

Viruses occupy a central place in ecology and health, influencing the dynamics of terrestrial, aquatic, and managed ...

Recludix Pharma, a clinical-stage company leading the discovery and development of inhibitors of challenging targets for ...

Doctors, scientists, and public health experts have urged the World Health Organization (WHO) to recommend that healthcare ...

This Research Topic invites high-impact research that advances nanotechnology-enabled antiviral interventions across the pipeline from molecular design to ...

AbbVie recently reported that Health Canada has approved MAVIRET (glecaprevir/pibrentasvir) for treating acute and chronic ...

Gilead Sciences and Assembly Biosciences have announced Gilead has exercised its combined option to exclusively license Assembly Bio’s herpes simplex virus (HSV) ...

Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the ...